122 related articles for article (PubMed ID: 19661031)
1. Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.
Gogou PN; Batistatou A; Pakos EE; Apostolikas N; Stefanou D; Tsekeris PG
Clin Transl Oncol; 2009 Aug; 11(8):548-51. PubMed ID: 19661031
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.
Gogou P; Pakos E; Batistatou A; Panelos I; Briasoulis E; Stefanou D; Apostolikas N; Tsekeris P
World J Surg Oncol; 2012 Feb; 10():28. PubMed ID: 22300273
[TBL] [Abstract][Full Text] [Related]
3. Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin.
Gaumann A; Tews DS; Mentzel T; Petrow PK; Mayer E; Otto M; Kirkpatrick CJ; Kriegsmann J
Virchows Arch; 2003 Jun; 442(6):529-37. PubMed ID: 12743815
[TBL] [Abstract][Full Text] [Related]
4. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin, b-catenin and topoisomerase II expression in rhabdomyosarcomas.
Gogou PN; Batistatou A; Pakos EE; Apostolikas N; Stefanou D; Tsekeris PG
J BUON; 2009; 14(2):323-4. PubMed ID: 19650189
[No Abstract] [Full Text] [Related]
7. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
Tian W; Wang G; Yang J; Pan Y; Ma Y
Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.
Wang Y; Coffey RJ; Osheroff N; Neufeld KL
PLoS One; 2010 Apr; 5(4):e9994. PubMed ID: 20368985
[TBL] [Abstract][Full Text] [Related]
9. Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.
Wang Y; Azuma Y; Moore D; Osheroff N; Neufeld KL
Mol Biol Cell; 2008 Oct; 19(10):4076-85. PubMed ID: 18632987
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
Winther TL; Torp SH
PLoS One; 2017; 12(3):e0172316. PubMed ID: 28301542
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
12. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):215-21. PubMed ID: 11556748
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical evaluation of topoisomerase IIalpha as proliferation factor in gastric lymphoma].
Ferariu D; Danciu M; Ciobanu D; Zugun F; Florea N; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):738-43. PubMed ID: 20201262
[TBL] [Abstract][Full Text] [Related]
14. Her-2/neu and topoisomerase IIα in advanced breast cancer: a comprehensive FISH analysis of 245 cases.
Engelstaedter V; Schiffers J; Kahlert S; Mainka P; Engel J; Kirchner T; Diebold J; Mayr D
Diagn Mol Pathol; 2012 Jun; 21(2):77-83. PubMed ID: 22555090
[TBL] [Abstract][Full Text] [Related]
15. The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues.
Turley H; Comley M; Houlbrook S; Nozaki N; Kikuchi A; Hickson ID; Gatter K; Harris AL
Br J Cancer; 1997; 75(9):1340-6. PubMed ID: 9155056
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia.
Chen CC; Gau JP; You JY; Lee KD; Yu YB; Lu CH; Lin JT; Lan C; Lo WH; Liu JM; Yang CF
Am J Hematol; 2009 Feb; 84(2):87-92. PubMed ID: 19127593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
